Axantia was established in 2014 to build a robust and differentiated, branded generics, Emerging Markets company. Axantia is committed to delivering high quality, innovative bio-pharmaceutical products to patients, payers, and caregivers. Axantia has a presence in over 20 countries across Africa, the Middle East and the CIS.
